Literature DB >> 17574042

Protein kinase C delta activated adhesion regulates vascular smooth muscle cell migration.

Kentaro Kamiya1, Evan Ryer, Kenji Sakakibara, Andrew Zohlman, K Craig Kent, Bo Liu.   

Abstract

BACKGROUND: Vascular smooth muscle cell (VSMC) migration, fundamental in the pathophysiology of atherogenesis and restenosis, is a coordinated process governed by the formation and disassembly of focal adhesions. Previous studies have demonstrated that VSMC migration is regulated via a signaling network involving protein kinase C delta (PKCdelta). In these studies, we test the hypothesis that PKCdelta regulates VSMC migration through modulation of cell adhesion.
MATERIALS AND METHODS: Using primary VSMCs isolated from PKCdelta wild type (+/+) and knock-out (-/-) mice, the effects of PKCdelta on VSMC migration and adhesion were assessed by chemotaxis and cell adhesion.
RESULTS: In evaluating cell migration, we found a decrease in platelet-derived growth factor-BB (PDGF-BB; 5 ng/mL x 6 h) stimulated migration of PKCdelta-/-VSMCs as compared to PKCdelta+/+VSMCs, by 59.4 +/- 5.9% (P < 0.01). A similar reduction in migration of PKCdelta-/-VSMCs (66.5 +/- 5.7%, P < 0.01) was also observed on collagen-coated (COL) membranes. Next, we examined cell attachment, a critical step of migration. PKCdelta-/-VSMCs exhibited significantly reduced adherence by 50.3 +/- 1.8% (P < 0.01). A similar defect of PKCdelta-/-VSMCs was also observed on the COL surface, 30.7 +/- 2.3% (P < 0.01). Interestingly, PDGF-BB did not stimulate attachment of VSMCs of either genotype. Consistent with these results, Rottlerin (2 microM), a selective inhibitor of PKCdelta, blocked migration and attachment of VSMCs by 56.8 +/- 3.4% (P < 0.01) and 37.7 +/- 1.9% (P < 0.01), respectively.
CONCLUSIONS: Taken together, our data indicate that PKCdelta activation is necessary for VSMC adhesion, which could, at least in part, contribute to the regulatory function of this kinase in cell migration thus pathogenesis of vascular lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574042     DOI: 10.1016/j.jss.2007.02.025

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Therapeutic potential for protein kinase C inhibitor in vascular restenosis.

Authors:  Richard Qinxue Ding; Jerry Tsao; Hong Chai; Daria Mochly-Rosen; Wei Zhou
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-12-23       Impact factor: 2.457

2.  Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells.

Authors:  Kaori Kato; Dai Yamanouchi; Karla Esbona; Kentaro Kamiya; Fan Zhang; K Craig Kent; Bo Liu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-16       Impact factor: 4.733

3.  mTOR Complexes Repress Hypertrophic Agonist-Stimulated Expression of Connective Tissue Growth Factor in Adult Cardiac Muscle Cells.

Authors:  Kamala Sundararaj; Dorea L Pleasant; Phillip C Moschella; Kavin Panneerselvam; Sundaravadivel Balasubramanian; Dhandapani Kuppuswamy
Journal:  J Cardiovasc Pharmacol       Date:  2016-02       Impact factor: 3.105

4.  The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury.

Authors:  Ashkaun Shaterian; Steven Kao; Lin Chen; Luisa A DiPietro; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  Arch Dermatol Res       Date:  2012-08-17       Impact factor: 3.017

Review 5.  Current siRNA targets in atherosclerosis and aortic aneurysm.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-05       Impact factor: 2.970

6.  Role of cGMP-dependent protein kinase in regulation of pulmonary vascular smooth muscle cell adhesion and migration: effect of hypoxia.

Authors:  S Negash; S R Narasimhan; W Zhou; J Liu; F L Wei; J Tian; J Usha Raj
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-01       Impact factor: 4.733

7.  Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.

Authors:  Francesca Graziano; Chiara Elia; Carlo Laudanna; Guido Poli; Massimo Alfano
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

8.  Transforming growth factor-beta promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells.

Authors:  Fan Zhang; Shirling Tsai; Kaori Kato; Dai Yamanouchi; Chunjie Wang; Shahin Rafii; Bo Liu; K Craig Kent
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

9.  PLCβ3 mediates cortactin interaction with WAVE2 in MCP1-induced actin polymerization and cell migration.

Authors:  Jagadeesh Janjanam; Giri Kumar Chandaka; Sivareddy Kotla; Gadiparthi N Rao
Journal:  Mol Biol Cell       Date:  2015-10-21       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.